A HOME DIAGNOSTIC PLATFORM

CONTRIBUTING
TO A BETTER LIFE 

Investors SARS-CoV-2

INVESTORS

Invitation

Invitation to exercise warrants of series TO 1 in Qlife 

Read more

Investors

Here you will find the share information for Qlife Holding AB. Our press releases and financial quarterly reports, our annual reports, calendar and information about our corporate governance work. Qlife Holding AB aims for a fast and transparent accounting to shareholders and the financial market.

The company is listed on Nasdaq, First North Growth Market, Stockholm as from March 2, 2020

Continue

Egoo.health

The Egoo product is a platform for accurate bio-marker testing. At a low cost and with equipment easy to use, it measures and analyses the patient’s blood. The patient can do the testing at home themselves. Read more on our product page.

Egoo.health
Read the Annual report 2020

Contact

If you have any questions, please send us a message.

 

 

You agree by using this feature that your information is handled in accordance with applicable GDPR legislation.
10 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Interview with Thomas Warthoe - NOVEMBER 2020
Interview with Peter Warthoe - NOVEMBER 2020

NEWS/PRESS

2021-10-14 15:20
Qlife to participate in investor presentations in December 2021
2021-09-21 16:30
Niklas Marschall leaves the Board of Qlife Holding AB
2021-08-16 08:30
QLIFE HOLDING AB INTERIM REPORT Q2, 2021
2021-07-15 12:16
Qlife has submitted a scientific study of the company's COVID-19 test for peer-review to be published in an international journal
2021-06-10 08:00
Qlife expands test capacity for Covid-19 during the European Football Championship in Copenhagen
2021-06-09 12:30
The ownership of Qlife's founders is divided into four owner companies
2021-06-02 08:00
Warrants of series TO 1 were subscribed to approximately 97.4 percent and Qlife Holding receives approximately SEK 38.1 million
2021-05-20 08:00
Board members of Qlife subscribe for warrants
2021-05-18 08:00
Qlife's Board of Directors and management exercise warrants of series TO1 for SEK 2.4 million
Film - EGOO HEALTH EXPLAINED

In less than four minutes, CEO Thomas Warthoe explains what Egoo Health is all about, how it works and why it makes a difference for ordinary people, medical staff and health institutions. 

Read more about us